nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—Spinal Cord Injury—TNFSF13B—rheumatoid arthritis	0.0151	0.0429	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—ACAN—rheumatoid arthritis	0.00866	0.0246	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CX3CR1—rheumatoid arthritis	0.00777	0.0221	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—ZFP36—rheumatoid arthritis	0.00772	0.022	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL6—rheumatoid arthritis	0.00695	0.0198	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MIF—rheumatoid arthritis	0.00679	0.0193	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR6—rheumatoid arthritis	0.00679	0.0193	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL21—rheumatoid arthritis	0.00663	0.0189	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNFSF13—rheumatoid arthritis	0.00656	0.0187	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—BDKRB2—rheumatoid arthritis	0.00528	0.015	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—COL2A1—rheumatoid arthritis	0.00515	0.0146	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—C5—rheumatoid arthritis	0.00497	0.0141	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL6—rheumatoid arthritis	0.00467	0.0133	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—FCGR2A—rheumatoid arthritis	0.00446	0.0127	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL21—rheumatoid arthritis	0.00445	0.0127	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL2—rheumatoid arthritis	0.00428	0.0122	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HSPD1—rheumatoid arthritis	0.00419	0.0119	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL13—rheumatoid arthritis	0.0041	0.0117	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CX3CR1—rheumatoid arthritis	0.00365	0.0104	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR5—rheumatoid arthritis	0.00362	0.0103	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.00355	0.0101	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—C5—rheumatoid arthritis	0.0034	0.00966	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL21—rheumatoid arthritis	0.00339	0.00964	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL10—rheumatoid arthritis	0.00321	0.00914	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR6—rheumatoid arthritis	0.00319	0.00909	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—GATA3—rheumatoid arthritis	0.00318	0.00904	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1RN—rheumatoid arthritis	0.00308	0.00876	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL2—rheumatoid arthritis	0.00292	0.00831	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL3—rheumatoid arthritis	0.00292	0.00831	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—SAA1—rheumatoid arthritis	0.00289	0.00823	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—SAA1—rheumatoid arthritis	0.00286	0.00813	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1A—rheumatoid arthritis	0.00277	0.00788	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.00275	0.00782	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL4—rheumatoid arthritis	0.00268	0.00762	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—SAA1—rheumatoid arthritis	0.00259	0.00736	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—BDKRB2—rheumatoid arthritis	0.00252	0.00716	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—ADRBK1—rheumatoid arthritis	0.00249	0.00708	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—BDKRB2—rheumatoid arthritis	0.00248	0.00707	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL12—rheumatoid arthritis	0.00248	0.00707	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.00245	0.00697	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—RASGRP1—rheumatoid arthritis	0.00235	0.00667	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—PRKCQ—rheumatoid arthritis	0.0023	0.00653	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.00228	0.00648	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—LEP—rheumatoid arthritis	0.00227	0.00645	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—rheumatoid arthritis	0.00225	0.0064	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—rheumatoid arthritis	0.00222	0.00633	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TLR4—rheumatoid arthritis	0.00222	0.00632	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1A—rheumatoid arthritis	0.00222	0.00631	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL10—rheumatoid arthritis	0.0022	0.00627	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.00219	0.00624	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.00214	0.00609	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—ICAM1—rheumatoid arthritis	0.00213	0.00606	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—NOS2—rheumatoid arthritis	0.00211	0.00601	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—rheumatoid arthritis	0.0021	0.00597	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.00209	0.00596	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—rheumatoid arthritis	0.00205	0.00584	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NR3C1—rheumatoid arthritis	0.00204	0.0058	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.00201	0.00571	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.00196	0.00557	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.00196	0.00557	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.00192	0.00545	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.00192	0.00545	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CCL2—rheumatoid arthritis	0.00191	0.00542	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.00189	0.00538	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.00187	0.00531	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.00182	0.00519	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—rheumatoid arthritis	0.00181	0.00516	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL21—rheumatoid arthritis	0.00174	0.00495	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—C5—rheumatoid arthritis	0.00173	0.00494	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR5—rheumatoid arthritis	0.0017	0.00484	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.00167	0.00474	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.00167	0.00474	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.00166	0.00473	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR6—rheumatoid arthritis	0.00163	0.00464	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IFNG—rheumatoid arthritis	0.00162	0.00461	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—PTGS2—rheumatoid arthritis	0.00155	0.00442	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.00152	0.00433	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6R—rheumatoid arthritis	0.00152	0.00432	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL8—rheumatoid arthritis	0.00151	0.00429	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL3—rheumatoid arthritis	0.00149	0.00424	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.00149	0.00424	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.00147	0.00419	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—SAA1—rheumatoid arthritis	0.00146	0.00415	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—rheumatoid arthritis	0.00145	0.00411	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL2—rheumatoid arthritis	0.00144	0.0041	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.00138	0.00393	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MMP9—rheumatoid arthritis	0.00136	0.00388	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.00133	0.00378	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—rheumatoid arthritis	0.00132	0.00375	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.0013	0.0037	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.00127	0.00361	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.00127	0.00361	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.00127	0.00361	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	0.0012	0.00343	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.00118	0.00337	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—rheumatoid arthritis	0.00118	0.00334	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	0.00116	0.00329	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.00114	0.00325	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TGFB1—rheumatoid arthritis	0.00112	0.00319	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.00112	0.00319	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.00112	0.00317	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	0.00108	0.00307	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL6—rheumatoid arthritis	0.00108	0.00306	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.00107	0.00306	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—rheumatoid arthritis	0.00107	0.00305	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—rheumatoid arthritis	0.00105	0.00298	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.00103	0.00293	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL21—rheumatoid arthritis	0.00103	0.00292	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SYVN1—rheumatoid arthritis	0.00103	0.00292	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.00102	0.00289	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000985	0.0028	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—C5—rheumatoid arthritis	0.00098	0.00279	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	0.000979	0.00278	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000965	0.00275	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000958	0.00272	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TP53—rheumatoid arthritis	0.000924	0.00263	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000922	0.00262	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000922	0.00262	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000892	0.00254	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—C5—rheumatoid arthritis	0.00089	0.00253	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000873	0.00248	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR5—rheumatoid arthritis	0.000869	0.00247	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—C3—rheumatoid arthritis	0.00085	0.00242	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL6—rheumatoid arthritis	0.000846	0.00241	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000843	0.0024	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	0.000839	0.00239	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000837	0.00238	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000825	0.00235	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000816	0.00232	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PLB1—rheumatoid arthritis	0.000779	0.00222	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000766	0.00218	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000766	0.00218	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000749	0.00213	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000719	0.00204	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000717	0.00204	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000717	0.00204	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000709	0.00202	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.00069	0.00196	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—rheumatoid arthritis	0.000679	0.00193	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	0.000677	0.00193	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000669	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000665	0.00189	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000654	0.00186	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000651	0.00185	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000651	0.00185	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000644	0.00183	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL13—rheumatoid arthritis	0.000635	0.00181	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.000634	0.0018	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000607	0.00173	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000594	0.00169	CbGpPWpGaD
Fosaprepitant—Syncope—Betamethasone—rheumatoid arthritis	0.000589	0.000908	CcSEcCtD
Fosaprepitant—Syncope—Dexamethasone—rheumatoid arthritis	0.000589	0.000908	CcSEcCtD
Fosaprepitant—Infection—Triamcinolone—rheumatoid arthritis	0.000587	0.000905	CcSEcCtD
Fosaprepitant—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000586	0.000904	CcSEcCtD
Fosaprepitant—Infection—Methylprednisolone—rheumatoid arthritis	0.000585	0.000903	CcSEcCtD
Fosaprepitant—Haematuria—Methotrexate—rheumatoid arthritis	0.000583	0.000899	CcSEcCtD
Fosaprepitant—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000581	0.000897	CcSEcCtD
Fosaprepitant—Vomiting—Leflunomide—rheumatoid arthritis	0.000581	0.000896	CcSEcCtD
Fosaprepitant—Shock—Triamcinolone—rheumatoid arthritis	0.000581	0.000896	CcSEcCtD
Fosaprepitant—Insomnia—Prednisolone—rheumatoid arthritis	0.000581	0.000896	CcSEcCtD
Fosaprepitant—Shock—Methylprednisolone—rheumatoid arthritis	0.00058	0.000894	CcSEcCtD
Fosaprepitant—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000578	0.000891	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000577	0.00089	CcSEcCtD
Fosaprepitant—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000577	0.00089	CcSEcCtD
Fosaprepitant—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000577	0.00089	CcSEcCtD
Fosaprepitant—Rash—Leflunomide—rheumatoid arthritis	0.000576	0.000889	CcSEcCtD
Fosaprepitant—Dermatitis—Leflunomide—rheumatoid arthritis	0.000576	0.000888	CcSEcCtD
Fosaprepitant—Mental disorder—Prednisone—rheumatoid arthritis	0.000575	0.000887	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000575	0.00164	CbGpPWpGaD
Fosaprepitant—Nausea—Azathioprine—rheumatoid arthritis	0.000575	0.000887	CcSEcCtD
Fosaprepitant—Headache—Leflunomide—rheumatoid arthritis	0.000573	0.000883	CcSEcCtD
Fosaprepitant—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000572	0.000882	CcSEcCtD
Fosaprepitant—Malnutrition—Prednisone—rheumatoid arthritis	0.000572	0.000882	CcSEcCtD
Fosaprepitant—Erythema—Prednisone—rheumatoid arthritis	0.000572	0.000882	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—TLE3—rheumatoid arthritis	0.000571	0.00163	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000571	0.00163	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000571	0.00088	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.00057	0.000878	CcSEcCtD
Fosaprepitant—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000567	0.000875	CcSEcCtD
Fosaprepitant—Hypertension—Dexamethasone—rheumatoid arthritis	0.000567	0.000874	CcSEcCtD
Fosaprepitant—Hypertension—Betamethasone—rheumatoid arthritis	0.000567	0.000874	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000566	0.00161	CbGpPWpGaD
Fosaprepitant—Urticaria—Cyclosporine—rheumatoid arthritis	0.000561	0.000864	CcSEcCtD
Fosaprepitant—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000558	0.00086	CcSEcCtD
Fosaprepitant—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000558	0.00086	CcSEcCtD
Fosaprepitant—Anxiety—Dexamethasone—rheumatoid arthritis	0.000557	0.000859	CcSEcCtD
Fosaprepitant—Anxiety—Betamethasone—rheumatoid arthritis	0.000557	0.000859	CcSEcCtD
Fosaprepitant—Discomfort—Betamethasone—rheumatoid arthritis	0.000552	0.000852	CcSEcCtD
Fosaprepitant—Discomfort—Dexamethasone—rheumatoid arthritis	0.000552	0.000852	CcSEcCtD
Fosaprepitant—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000552	0.000851	CcSEcCtD
Fosaprepitant—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000551	0.000849	CcSEcCtD
Fosaprepitant—Pain—Prednisolone—rheumatoid arthritis	0.000549	0.000847	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000545	0.00155	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000545	0.000841	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000545	0.00155	CbGpPWpGaD
Fosaprepitant—Nausea—Leflunomide—rheumatoid arthritis	0.000543	0.000837	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000542	0.000836	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000541	0.000835	CcSEcCtD
Fosaprepitant—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000541	0.000834	CcSEcCtD
Fosaprepitant—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000538	0.00083	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000537	0.00153	CbGpPWpGaD
Fosaprepitant—Pain—Hydrocortisone—rheumatoid arthritis	0.000536	0.000827	CcSEcCtD
Fosaprepitant—Oedema—Dexamethasone—rheumatoid arthritis	0.000536	0.000826	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000536	0.000826	CcSEcCtD
Fosaprepitant—Oedema—Betamethasone—rheumatoid arthritis	0.000536	0.000826	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000536	0.000826	CcSEcCtD
Fosaprepitant—Insomnia—Triamcinolone—rheumatoid arthritis	0.000534	0.000824	CcSEcCtD
Fosaprepitant—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000533	0.000822	CcSEcCtD
Fosaprepitant—Infection—Betamethasone—rheumatoid arthritis	0.000532	0.000821	CcSEcCtD
Fosaprepitant—Infection—Dexamethasone—rheumatoid arthritis	0.000532	0.000821	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.00053	0.000818	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000529	0.000816	CcSEcCtD
Fosaprepitant—Anaemia—Prednisone—rheumatoid arthritis	0.000528	0.000815	CcSEcCtD
Fosaprepitant—Shock—Betamethasone—rheumatoid arthritis	0.000527	0.000813	CcSEcCtD
Fosaprepitant—Shock—Dexamethasone—rheumatoid arthritis	0.000527	0.000813	CcSEcCtD
Fosaprepitant—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000526	0.000812	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—C5—rheumatoid arthritis	0.000526	0.0015	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000526	0.0015	CbGpPWpGaD
Fosaprepitant—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000525	0.00081	CcSEcCtD
Fosaprepitant—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000525	0.00081	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000525	0.00149	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.000524	0.00149	CbGpPWpGaD
Fosaprepitant—Angioedema—Prednisone—rheumatoid arthritis	0.000522	0.000806	CcSEcCtD
Fosaprepitant—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00052	0.000802	CcSEcCtD
Fosaprepitant—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00052	0.000802	CcSEcCtD
Fosaprepitant—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.000519	0.0008	CcSEcCtD
Fosaprepitant—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000519	0.0008	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000518	0.000799	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000518	0.000799	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000517	0.00147	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000517	0.000797	CcSEcCtD
Fosaprepitant—Malaise—Prednisone—rheumatoid arthritis	0.000516	0.000795	CcSEcCtD
Fosaprepitant—Eye disorder—Methotrexate—rheumatoid arthritis	0.000513	0.000791	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000513	0.000791	CcSEcCtD
Fosaprepitant—Syncope—Prednisone—rheumatoid arthritis	0.000513	0.000791	CcSEcCtD
Fosaprepitant—Tinnitus—Methotrexate—rheumatoid arthritis	0.000512	0.000789	CcSEcCtD
Fosaprepitant—Urticaria—Prednisolone—rheumatoid arthritis	0.00051	0.000787	CcSEcCtD
Fosaprepitant—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000509	0.000785	CcSEcCtD
Fosaprepitant—Fatigue—Triamcinolone—rheumatoid arthritis	0.000509	0.000785	CcSEcCtD
Fosaprepitant—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000508	0.000783	CcSEcCtD
Fosaprepitant—Asthenia—Cyclosporine—rheumatoid arthritis	0.000506	0.000781	CcSEcCtD
Fosaprepitant—Pain—Triamcinolone—rheumatoid arthritis	0.000505	0.000779	CcSEcCtD
Fosaprepitant—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000502	0.000775	CcSEcCtD
Fosaprepitant—Hypotension—Dexamethasone—rheumatoid arthritis	0.000501	0.000772	CcSEcCtD
Fosaprepitant—Hypotension—Betamethasone—rheumatoid arthritis	0.000501	0.000772	CcSEcCtD
Fosaprepitant—Pruritus—Cyclosporine—rheumatoid arthritis	0.000499	0.00077	CcSEcCtD
Fosaprepitant—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000498	0.000768	CcSEcCtD
Fosaprepitant—Angiopathy—Methotrexate—rheumatoid arthritis	0.000498	0.000768	CcSEcCtD
Fosaprepitant—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000496	0.000764	CcSEcCtD
Fosaprepitant—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000496	0.000764	CcSEcCtD
Fosaprepitant—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000496	0.000764	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000495	0.00141	CbGpPWpGaD
Fosaprepitant—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000495	0.000763	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR6—rheumatoid arthritis	0.000494	0.00141	CbGpPWpGaD
Fosaprepitant—Hypertension—Prednisone—rheumatoid arthritis	0.000494	0.000761	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000491	0.0014	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000488	0.00139	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000487	0.00075	CcSEcCtD
Fosaprepitant—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000486	0.000749	CcSEcCtD
Fosaprepitant—Anxiety—Prednisone—rheumatoid arthritis	0.000485	0.000748	CcSEcCtD
Fosaprepitant—Insomnia—Betamethasone—rheumatoid arthritis	0.000485	0.000747	CcSEcCtD
Fosaprepitant—Insomnia—Dexamethasone—rheumatoid arthritis	0.000485	0.000747	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000484	0.00138	CbGpPWpGaD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000483	0.000745	CcSEcCtD
Fosaprepitant—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000483	0.000744	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000482	0.000743	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NCF2—rheumatoid arthritis	0.000481	0.00137	CbGpPWpGaD
Fosaprepitant—Discomfort—Prednisone—rheumatoid arthritis	0.000481	0.000742	CcSEcCtD
Fosaprepitant—Mental disorder—Methotrexate—rheumatoid arthritis	0.000481	0.000741	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—C3—rheumatoid arthritis	0.00048	0.00137	CbGpPWpGaD
Fosaprepitant—Erythema—Methotrexate—rheumatoid arthritis	0.000478	0.000737	CcSEcCtD
Fosaprepitant—Malnutrition—Methotrexate—rheumatoid arthritis	0.000478	0.000737	CcSEcCtD
Fosaprepitant—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000473	0.000729	CcSEcCtD
Fosaprepitant—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000472	0.000727	CcSEcCtD
Fosaprepitant—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000472	0.000727	CcSEcCtD
Fosaprepitant—Urticaria—Triamcinolone—rheumatoid arthritis	0.000469	0.000723	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000469	0.00133	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000469	0.00133	CbGpPWpGaD
Fosaprepitant—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000468	0.000722	CcSEcCtD
Fosaprepitant—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000468	0.000721	CcSEcCtD
Fosaprepitant—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000467	0.00072	CcSEcCtD
Fosaprepitant—Dizziness—Cyclosporine—rheumatoid arthritis	0.000467	0.00072	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000467	0.000719	CcSEcCtD
Fosaprepitant—Oedema—Prednisone—rheumatoid arthritis	0.000467	0.000719	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—GZMB—rheumatoid arthritis	0.000466	0.00133	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000466	0.000718	CcSEcCtD
Fosaprepitant—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000466	0.000718	CcSEcCtD
Fosaprepitant—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000466	0.000718	CcSEcCtD
Fosaprepitant—Infection—Prednisone—rheumatoid arthritis	0.000464	0.000715	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000463	0.000713	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000463	0.000713	CcSEcCtD
Fosaprepitant—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000462	0.000712	CcSEcCtD
Fosaprepitant—Fatigue—Dexamethasone—rheumatoid arthritis	0.000462	0.000712	CcSEcCtD
Fosaprepitant—Fatigue—Betamethasone—rheumatoid arthritis	0.000462	0.000712	CcSEcCtD
Fosaprepitant—Shock—Prednisone—rheumatoid arthritis	0.000459	0.000708	CcSEcCtD
Fosaprepitant—Pain—Dexamethasone—rheumatoid arthritis	0.000458	0.000707	CcSEcCtD
Fosaprepitant—Pain—Betamethasone—rheumatoid arthritis	0.000458	0.000707	CcSEcCtD
Fosaprepitant—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000458	0.000706	CcSEcCtD
Fosaprepitant—Skin disorder—Prednisone—rheumatoid arthritis	0.000453	0.000699	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCL3—rheumatoid arthritis	0.000452	0.00129	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000452	0.00129	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000451	0.000696	CcSEcCtD
Fosaprepitant—Asthenia—Hydrocortisone—rheumatoid arthritis	0.00045	0.000694	CcSEcCtD
Fosaprepitant—Vomiting—Cyclosporine—rheumatoid arthritis	0.000449	0.000692	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000446	0.00127	CbGpPWpGaD
Fosaprepitant—Rash—Cyclosporine—rheumatoid arthritis	0.000445	0.000686	CcSEcCtD
Fosaprepitant—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000445	0.000685	CcSEcCtD
Fosaprepitant—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000444	0.000684	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000443	0.000684	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SAA1—rheumatoid arthritis	0.000442	0.00126	CbGpPWpGaD
Fosaprepitant—Headache—Cyclosporine—rheumatoid arthritis	0.000442	0.000682	CcSEcCtD
Fosaprepitant—Anaemia—Methotrexate—rheumatoid arthritis	0.000442	0.000681	CcSEcCtD
Fosaprepitant—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000442	0.000681	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000442	0.000681	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.00044	0.00125	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000438	0.000676	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000438	0.000676	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—C3—rheumatoid arthritis	0.000436	0.00124	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000435	0.000671	CcSEcCtD
Fosaprepitant—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000434	0.000669	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NCF1—rheumatoid arthritis	0.000433	0.00123	CbGpPWpGaD
Fosaprepitant—Malaise—Methotrexate—rheumatoid arthritis	0.000431	0.000664	CcSEcCtD
Fosaprepitant—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000429	0.000662	CcSEcCtD
Fosaprepitant—Urticaria—Dexamethasone—rheumatoid arthritis	0.000426	0.000656	CcSEcCtD
Fosaprepitant—Urticaria—Betamethasone—rheumatoid arthritis	0.000426	0.000656	CcSEcCtD
Fosaprepitant—Dizziness—Prednisolone—rheumatoid arthritis	0.000425	0.000655	CcSEcCtD
Fosaprepitant—Asthenia—Triamcinolone—rheumatoid arthritis	0.000424	0.000653	CcSEcCtD
Fosaprepitant—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000424	0.000653	CcSEcCtD
Fosaprepitant—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000424	0.000653	CcSEcCtD
Fosaprepitant—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000424	0.000653	CcSEcCtD
Fosaprepitant—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000424	0.000653	CcSEcCtD
Fosaprepitant—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000423	0.000652	CcSEcCtD
Fosaprepitant—Insomnia—Prednisone—rheumatoid arthritis	0.000422	0.000651	CcSEcCtD
Fosaprepitant—Nausea—Cyclosporine—rheumatoid arthritis	0.000419	0.000646	CcSEcCtD
Fosaprepitant—Pruritus—Triamcinolone—rheumatoid arthritis	0.000418	0.000644	CcSEcCtD
Fosaprepitant—Cough—Methotrexate—rheumatoid arthritis	0.000417	0.000643	CcSEcCtD
Fosaprepitant—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000417	0.000643	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CD28—rheumatoid arthritis	0.000417	0.00118	CbGpPWpGaD
Fosaprepitant—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000415	0.000639	CcSEcCtD
Fosaprepitant—Dyspepsia—Prednisone—rheumatoid arthritis	0.000411	0.000633	CcSEcCtD
Fosaprepitant—Chest pain—Methotrexate—rheumatoid arthritis	0.000407	0.000627	CcSEcCtD
Fosaprepitant—Decreased appetite—Prednisone—rheumatoid arthritis	0.000406	0.000625	CcSEcCtD
Fosaprepitant—Rash—Prednisolone—rheumatoid arthritis	0.000405	0.000624	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisolone—rheumatoid arthritis	0.000404	0.000624	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000404	0.000623	CcSEcCtD
Fosaprepitant—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000403	0.000622	CcSEcCtD
Fosaprepitant—Fatigue—Prednisone—rheumatoid arthritis	0.000402	0.00062	CcSEcCtD
Fosaprepitant—Headache—Prednisolone—rheumatoid arthritis	0.000402	0.00062	CcSEcCtD
Fosaprepitant—Discomfort—Methotrexate—rheumatoid arthritis	0.000402	0.00062	CcSEcCtD
Fosaprepitant—Constipation—Prednisone—rheumatoid arthritis	0.000399	0.000615	CcSEcCtD
Fosaprepitant—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000399	0.000615	CcSEcCtD
Fosaprepitant—Rash—Hydrocortisone—rheumatoid arthritis	0.000395	0.00061	CcSEcCtD
Fosaprepitant—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000395	0.000609	CcSEcCtD
Fosaprepitant—Headache—Hydrocortisone—rheumatoid arthritis	0.000393	0.000606	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000392	0.00112	CbGpPWpGaD
Fosaprepitant—Dizziness—Triamcinolone—rheumatoid arthritis	0.00039	0.000602	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.00039	0.000601	CcSEcCtD
Fosaprepitant—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00039	0.000601	CcSEcCtD
Fosaprepitant—Infection—Methotrexate—rheumatoid arthritis	0.000387	0.000597	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000385	0.00109	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000385	0.00109	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000385	0.000593	CcSEcCtD
Fosaprepitant—Asthenia—Betamethasone—rheumatoid arthritis	0.000384	0.000593	CcSEcCtD
Fosaprepitant—Asthenia—Dexamethasone—rheumatoid arthritis	0.000384	0.000593	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000384	0.00109	CbGpPWpGaD
Fosaprepitant—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000382	0.00059	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000382	0.000588	CcSEcCtD
Fosaprepitant—Nausea—Prednisolone—rheumatoid arthritis	0.000381	0.000588	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000381	0.00108	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.00038	0.00108	CbGpPWpGaD
Fosaprepitant—Pruritus—Dexamethasone—rheumatoid arthritis	0.000379	0.000585	CcSEcCtD
Fosaprepitant—Pruritus—Betamethasone—rheumatoid arthritis	0.000379	0.000585	CcSEcCtD
Fosaprepitant—Skin disorder—Methotrexate—rheumatoid arthritis	0.000379	0.000584	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000377	0.000581	CcSEcCtD
Fosaprepitant—Vomiting—Triamcinolone—rheumatoid arthritis	0.000375	0.000579	CcSEcCtD
Fosaprepitant—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000375	0.000578	CcSEcCtD
Fosaprepitant—Nausea—Hydrocortisone—rheumatoid arthritis	0.000372	0.000574	CcSEcCtD
Fosaprepitant—Rash—Triamcinolone—rheumatoid arthritis	0.000372	0.000574	CcSEcCtD
Fosaprepitant—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000372	0.000574	CcSEcCtD
Fosaprepitant—Rash—Methylprednisolone—rheumatoid arthritis	0.000371	0.000573	CcSEcCtD
Fosaprepitant—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000371	0.000572	CcSEcCtD
Fosaprepitant—Urticaria—Prednisone—rheumatoid arthritis	0.000371	0.000572	CcSEcCtD
Fosaprepitant—Headache—Triamcinolone—rheumatoid arthritis	0.00037	0.00057	CcSEcCtD
Fosaprepitant—Headache—Methylprednisolone—rheumatoid arthritis	0.000369	0.000569	CcSEcCtD
Fosaprepitant—Abdominal pain—Prednisone—rheumatoid arthritis	0.000369	0.000569	CcSEcCtD
Fosaprepitant—Body temperature increased—Prednisone—rheumatoid arthritis	0.000369	0.000569	CcSEcCtD
Fosaprepitant—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000367	0.000565	CcSEcCtD
Fosaprepitant—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000367	0.000565	CcSEcCtD
Fosaprepitant—Hypotension—Methotrexate—rheumatoid arthritis	0.000364	0.000562	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000359	0.00102	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SYK—rheumatoid arthritis	0.000358	0.00102	CbGpPWpGaD
Fosaprepitant—Dizziness—Dexamethasone—rheumatoid arthritis	0.000354	0.000546	CcSEcCtD
Fosaprepitant—Dizziness—Betamethasone—rheumatoid arthritis	0.000354	0.000546	CcSEcCtD
Fosaprepitant—Insomnia—Methotrexate—rheumatoid arthritis	0.000353	0.000544	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000351	0.000998	CbGpPWpGaD
Fosaprepitant—Nausea—Triamcinolone—rheumatoid arthritis	0.000351	0.000541	CcSEcCtD
Fosaprepitant—Nausea—Methylprednisolone—rheumatoid arthritis	0.00035	0.00054	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—rheumatoid arthritis	0.000349	0.000992	CbGpPWpGaD
Fosaprepitant—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000348	0.000536	CcSEcCtD
Fosaprepitant—Somnolence—Methotrexate—rheumatoid arthritis	0.000347	0.000535	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—STAT1—rheumatoid arthritis	0.000345	0.000981	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000344	0.00053	CcSEcCtD
Fosaprepitant—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000343	0.000529	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000341	0.000971	CbGpPWpGaD
Fosaprepitant—Vomiting—Betamethasone—rheumatoid arthritis	0.000341	0.000525	CcSEcCtD
Fosaprepitant—Vomiting—Dexamethasone—rheumatoid arthritis	0.000341	0.000525	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL6R—rheumatoid arthritis	0.00034	0.000968	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL10—rheumatoid arthritis	0.00034	0.000967	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000339	0.000523	CcSEcCtD
Fosaprepitant—Rash—Dexamethasone—rheumatoid arthritis	0.000338	0.000521	CcSEcCtD
Fosaprepitant—Rash—Betamethasone—rheumatoid arthritis	0.000338	0.000521	CcSEcCtD
Fosaprepitant—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000338	0.00052	CcSEcCtD
Fosaprepitant—Dermatitis—Betamethasone—rheumatoid arthritis	0.000338	0.00052	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000337	0.000519	CcSEcCtD
Fosaprepitant—Fatigue—Methotrexate—rheumatoid arthritis	0.000336	0.000518	CcSEcCtD
Fosaprepitant—Headache—Betamethasone—rheumatoid arthritis	0.000336	0.000518	CcSEcCtD
Fosaprepitant—Headache—Dexamethasone—rheumatoid arthritis	0.000336	0.000518	CcSEcCtD
Fosaprepitant—Asthenia—Prednisone—rheumatoid arthritis	0.000335	0.000516	CcSEcCtD
Fosaprepitant—Pain—Methotrexate—rheumatoid arthritis	0.000333	0.000514	CcSEcCtD
Fosaprepitant—Pruritus—Prednisone—rheumatoid arthritis	0.00033	0.000509	CcSEcCtD
Fosaprepitant—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000321	0.000496	CcSEcCtD
Fosaprepitant—Diarrhoea—Prednisone—rheumatoid arthritis	0.000319	0.000492	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000319	0.000492	CcSEcCtD
Fosaprepitant—Nausea—Betamethasone—rheumatoid arthritis	0.000318	0.000491	CcSEcCtD
Fosaprepitant—Nausea—Dexamethasone—rheumatoid arthritis	0.000318	0.000491	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—MMP3—rheumatoid arthritis	0.00031	0.000882	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TYK2—rheumatoid arthritis	0.00031	0.000881	CbGpPWpGaD
Fosaprepitant—Urticaria—Methotrexate—rheumatoid arthritis	0.00031	0.000478	CcSEcCtD
Fosaprepitant—Dizziness—Prednisone—rheumatoid arthritis	0.000309	0.000476	CcSEcCtD
Fosaprepitant—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000308	0.000475	CcSEcCtD
Fosaprepitant—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000308	0.000475	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PTK2—rheumatoid arthritis	0.000298	0.000849	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000297	0.000845	CbGpPWpGaD
Fosaprepitant—Vomiting—Prednisone—rheumatoid arthritis	0.000297	0.000457	CcSEcCtD
Fosaprepitant—Rash—Prednisone—rheumatoid arthritis	0.000294	0.000454	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisone—rheumatoid arthritis	0.000294	0.000453	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCL5—rheumatoid arthritis	0.000293	0.000832	CbGpPWpGaD
Fosaprepitant—Headache—Prednisone—rheumatoid arthritis	0.000292	0.000451	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CSF2—rheumatoid arthritis	0.000288	0.00082	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000287	0.000443	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000284	0.000808	CbGpPWpGaD
Fosaprepitant—Asthenia—Methotrexate—rheumatoid arthritis	0.00028	0.000431	CcSEcCtD
Fosaprepitant—Nausea—Prednisone—rheumatoid arthritis	0.000277	0.000427	CcSEcCtD
Fosaprepitant—Pruritus—Methotrexate—rheumatoid arthritis	0.000276	0.000425	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SPP1—rheumatoid arthritis	0.000271	0.000771	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.00027	0.000767	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000267	0.000411	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR5—rheumatoid arthritis	0.000264	0.00075	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL2RA—rheumatoid arthritis	0.00026	0.000739	CbGpPWpGaD
Fosaprepitant—Dizziness—Methotrexate—rheumatoid arthritis	0.000258	0.000398	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL2—rheumatoid arthritis	0.000258	0.000733	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C3—rheumatoid arthritis	0.000258	0.000733	CbGpPWpGaD
Fosaprepitant—Vomiting—Methotrexate—rheumatoid arthritis	0.000248	0.000382	CcSEcCtD
Fosaprepitant—Rash—Methotrexate—rheumatoid arthritis	0.000246	0.000379	CcSEcCtD
Fosaprepitant—Dermatitis—Methotrexate—rheumatoid arthritis	0.000246	0.000379	CcSEcCtD
Fosaprepitant—Headache—Methotrexate—rheumatoid arthritis	0.000244	0.000377	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—LEP—rheumatoid arthritis	0.00024	0.000682	CbGpPWpGaD
Fosaprepitant—Nausea—Methotrexate—rheumatoid arthritis	0.000232	0.000357	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—FN1—rheumatoid arthritis	0.000226	0.000643	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000225	0.000641	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CD80—rheumatoid arthritis	0.000217	0.000617	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—rheumatoid arthritis	0.000206	0.000586	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL2—rheumatoid arthritis	0.000202	0.000573	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6R—rheumatoid arthritis	0.000201	0.000572	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TYK2—rheumatoid arthritis	0.000183	0.000521	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOS3—rheumatoid arthritis	0.00018	0.000511	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL8—rheumatoid arthritis	0.000159	0.000453	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL2—rheumatoid arthritis	0.000152	0.000433	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—rheumatoid arthritis	0.000152	0.000431	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—rheumatoid arthritis	0.000144	0.00041	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NFKB1—rheumatoid arthritis	0.000143	0.000406	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MAPK8—rheumatoid arthritis	0.00014	0.000399	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—rheumatoid arthritis	0.000129	0.000368	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—rheumatoid arthritis	0.000119	0.000338	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TP53—rheumatoid arthritis	9.78e-05	0.000278	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—rheumatoid arthritis	8.95e-05	0.000255	CbGpPWpGaD
